KOCH KEVIN
SEC CIK 1185829 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| EWTX | Edgewise Therapeutics, Inc. | Pres, CEO, Dir | 70.5K | — | $1.34M | 14 | 2023-05-01 | 2026-08-12 |
Most active insiders at EWTX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Russell Alan J | CSO, Dir | — | $10.25M |
| 2 | Donovan Joanne M. | CMO | — | $4.62M |
| 3 | Edris Badreddin | Dir | — | $3.40M |
| 4 | KOCH KEVIN | Pres, CEO, Dir | — | $785.0K |
| 5 | Derakhshan Behrad | Chief Business Off | — | $223.4K |
| 6 | MOORE JOHN R | GC | — | $219.8K |
| 7 | Fox Jonathan C | Dir | $199.4K | — |
Transactions 14
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-08-14 16:52 | 2026-08-12 | EWTX | Edgewise Therapeutics, Inc. | KOCH KEVIN | Pres, CEO, Dir | M - OptEx | $0.00 | +39.8K | 70.5K | +130% | $0 |
| DM | 2026-08-14 16:52 | 2026-08-12 | EWTX | Edgewise Therapeutics, Inc. | KOCH KEVIN | Pres, CEO, Dir | S - Sale+OE | $43.68 | -18.0K | 52.5K | -26% | -$785.0K |
| D | 2025-08-14 | 2025-08-12 | EWTX | Edgewise Therapeutics, Inc. | KOCH KEVIN | Pres, CEO, Dir | S - Sale+OE | $13.39 | -7,972 | 30.6K | -21% | -$106.7K |
| D | 2025-08-14 | 2025-08-12 | EWTX | Edgewise Therapeutics, Inc. | KOCH KEVIN | Pres, CEO, Dir | M - OptEx | $0.00 | +18.0K | 38.6K | +87% | $0 |
| D | 2025-05-07 | 2025-05-01 | EWTX | Edgewise Therapeutics, Inc. | KOCH KEVIN | Pres, CEO, Dir | M - OptEx | $0.00 | +10.4K | 24.9K | +72% | $0 |
| D | 2025-05-07 | 2025-05-02 | EWTX | Edgewise Therapeutics, Inc. | KOCH KEVIN | Pres, CEO, Dir | S - Sale+OE | $16.45 | -4,276 | 20.6K | -17% | -$70.3K |
| DT | 2025-03-11 | 2025-03-07 | EWTX | Edgewise Therapeutics, Inc. | KOCH KEVIN | Pres, CEO, Dir | S - Sale+OE | $30.00 | -100 | 14.5K | -0.7% | -$3,000 |
| DT | 2025-03-11 | 2025-03-07 | EWTX | Edgewise Therapeutics, Inc. | KOCH KEVIN | Pres, CEO, Dir | M - OptEx | $0.18 | +100 | 14.6K | +0.7% | +$18 |
| DMT | 2025-02-07 | 2025-02-05+ | EWTX | Edgewise Therapeutics, Inc. | KOCH KEVIN | Pres, CEO, Dir | M - OptEx | $1.40 | +9,536 | 15.4K | +163% | +$13.4K |
| DMT | 2025-02-07 | 2025-02-05+ | EWTX | Edgewise Therapeutics, Inc. | KOCH KEVIN | Pres, CEO, Dir | S - Sale+OE | $30.13 | -9,536 | 14.5K | -40% | -$287.4K |
| D | 2024-05-03 | 2024-05-01 | EWTX | Edgewise Therapeutics, Inc. | KOCH KEVIN | Pres, CEO, Dir | M - OptEx | $0.00 | +10.4K | 17.6K | +144% | $0 |
| D | 2024-05-03 | 2024-05-02 | EWTX | Edgewise Therapeutics, Inc. | KOCH KEVIN | Pres, CEO, Dir | S - Sale+OE | $18.91 | -3,152 | 14.5K | -18% | -$59.6K |
| D | 2023-05-03 | 2023-05-02 | EWTX | Edgewise Therapeutics, Inc. | KOCH KEVIN | Pres, CEO, Dir | S - Sale+OE | $8.90 | -3,203 | 7,213 | -31% | -$28.5K |
| D | 2023-05-03 | 2023-05-01 | EWTX | Edgewise Therapeutics, Inc. | KOCH KEVIN | Pres, CEO, Dir | M - OptEx | $0.00 | +10.4K | 10.4K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations